Skip to main content

Latest stock market podcasts

Part 2 Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 30 April

Grady Wulff
April 30, 2025

Morning Bell 29 April

Sophia Mavridis
April 29, 2025

Morning Bell 28 April

Grady Wulff
April 28, 2025

Morning Bell 24 April

Sophia Mavridis
April 24, 2025

Morning Bell 23 April

Sophia Mavridis
April 23, 2025

Morning Bell 22 April

Sam Kanaan
April 22, 2025

Morning Bell 17 April

Bell Direct
April 17, 2025

Morning Bell 16 April

Bell Direct
April 16, 2025

Morning Bell 15 April

Bell Direct
April 15, 2025

Morning Bell 14 April

Bell Direct
April 14, 2025

Weekly Wrap 11 April

Bell Direct
April 11, 2025

Morning Bell 10 April

Bell Direct
April 10, 2025